Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Lower plasma resolvin D1 level and greater sputum eosinophilia characterize a cluster of severe asthma patients.

Respiratory research·2026

Same author

Whole Genome Sequence Analysis of Weight Loss in 16 972 Participants With COPD Reveals Novel Risk Loci in DRAIC and RFX3.

Journal of cachexia, sarcopenia and muscle·2026

Same author

Epigenomic study of the lower airway reveals COPD-associated methylation patterns and potential microbiota links.

BMJ open respiratory research·2025

Same author

Hair follicle gene expression profiling in the SubPopulations and InteRmediate Outcome Measures in COPD Study (SPIROMICS).

BMC medical genomics·2025

Same author

Genetic architecture and analysis practices of circulating metabolites in the NHLBI Trans-Omics for Precision Medicine Program.

American journal of human genetics·2025

Same author

Serum IgA isotypes are associated with percent emphysema, wall thickness and lung function decline.

Thorax·2025

Search research articles

Related Experiment Video

Updated: Jun 14, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Do symptoms predict COPD in smokers?

Jill A Ohar¹, Alireza Sadeghnejad, Deborah A Meyers

¹Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157, USA. johar@wfubmc.edu

|April 6, 2010

Summary

Chronic obstructive pulmonary disease (COPD) is underdiagnosed in the US. Screening older smokers, rather than relying on symptoms, may be a more effective approach to identify cases.

Related Experiment Videos

Last Updated: Jun 14, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

Area of Science:

Pulmonary Medicine
Epidemiology
Preventive Health

Background:

The US Preventive Services Task Force advises against spirometry without symptoms, contributing to significant undiagnosed Chronic Obstructive Pulmonary Disease (COPD) in the United States.
Approximately 50% of COPD cases remain undiagnosed in the US.

Purpose of the Study:

To assess the prevalence of airflow obstruction and respiratory symptoms in a screened population.
To evaluate the predictive value of symptoms and smoking history for diagnosing COPD.
To determine the effectiveness of spirometry versus symptom-based screening for COPD.

Main Methods:

Collected data on symptoms, smoking history, and spirometry from 3,955 subjects undergoing medical evaluation.
Assessed the prevalence of airflow obstruction and respiratory symptoms.
Calculated sensitivity, specificity, and predictive values for COPD prediction using symptoms and smoking history.

Main Results:

44% of smokers exhibited airflow obstruction (AO), with 36% of those diagnosed with or treated for COPD.
Smoking (≥20 pack-years) significantly increased the odds of AO (OR 3.73).
Respiratory symptoms were common in smokers with AO (92%) but had poor predictive value for COPD when added to age and smoking history.

Conclusions:

COPD is underdiagnosed in the US, despite frequent respiratory symptoms in individuals with airflow obstruction.
Symptoms alone have limited predictive value for COPD beyond age and smoking history.
Screening older smokers using a simpler approach than symptom-based evaluation is recommended due to high symptom prevalence and poor predictive value.